Research indicates that NALCN expression is observed in certain cancers, including glioblastoma, non-small cell lung cancer (NSCLC), pancreatic cancer, small cell lung cancer (SCLC), and tumor-derived endothelial cells (24–26). Here, NALCN is linked to pancreatic neoplasm.